PubMed HealthSearch

Biomedical subjects

A Trojan

Publications and source records attributed to A Trojan.

9 recordsLinked to original sources

Benefits of self-help groups: a survey of 232 members from 65 disease-related groups.

This paper gives a report on the benefits of self-help groups as depicted by 232 members from 65 different disease-related groups. Intensive interviews and participant observation enabled us to formulate a questionnaire with 125 mostly standardized questions. The questions referred mainly to motives for membership, working procedures within the groups, goals and effectiveness, outcome of participation and need for outside support. The focus of this paper will be on what the members reported about the changes and effects induced by their participation in self-help groups. The interviewed group members reported a wide variety of goals. These were classified into two categories according to their range. Goals directed towards the group or group members were achieved (at least partly) by more than 90%. Goals directed towards persons outside the group (e.g. to change opinions of the family or of the professional system) were mentioned by about two thirds of the interviewed members. About three quarters of them achieved these goals at least partly. The effects of participation were grouped into the following categories. 1--Impact on disease-related stress (positive health effects, general enlargement of competence, general social activation); 2--impact on the relationship with family and friends (relationship with partner, changes in personal network); 3--impact on patient behaviour and professional services (general enlargement of competence in relation to the professional care system, social activation in relation to the professional care system, utilization of professional services). Most of the members reported considerable positive changes in these dimensions. Negative impacts were mentioned by a very small minority (between 1 and 4%).(ABSTRACT TRUNCATED AT 250 WORDS)

Health Behavior

Tilidine abuse and dependence.

Tilidine (Valoron) is a new strong analgesic which was introduced into the market in West Germany in 1970. In February 1978 tilidine was placed under the regulations of the German Narcotics Act because it had rapidly become an easily acquired substitute for opiates on the drug scene. Cases have become known where tilidine dependence developed during the treatment of pain in patients without any preceding addiction to other drugs. The relevant literature on tilidine is reviewed in regard to pharmacological, epidemiological and clinical aspects of tilidine dependence and abuse.

Adult

[Tilidin (Valoron) abuse. Results of an enquiry of drug consumers (author's transl)].

Contrary to previous clinical reports tilidin (Valoron), valuable as a strong analgesic, can replace opiates in young people addicted to them. In the drug scene, therefore, Valoron - very often through irresponsible medical prescription - has become a substitute for opiates. The results of an enquiry about Valoron abuse in 44 opiate addicts are reported. Four cases of isolated Valoron addiction are included which were indistinguishable from the typical career of an opium addict. Further cases of Valoron abuse, estimated at 600, have been mentioned to us, partly by name and partly by number. Doctors and pharmacists are urgently advised to treat Valoron with the same caution prescribed for opiates by the Betäubungsmittelgesetz (= Narcotics Act).

Adolescent